These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7827407)

  • 41. Biologically active synthetic fragments of human basic fibroblast growth factor (bFGF): identification of two Asp-Gly-Arg-containing domains involved in the mitogenic activity of bFGF in endothelial cells.
    Presta M; Rusnati M; Urbinati C; Sommer A; Ragnotti G
    J Cell Physiol; 1991 Dec; 149(3):512-24. PubMed ID: 1660485
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulation of FGF-1 mitogenic activity by heparan sulfate oligosaccharides is dependent on specific structural features: differential requirements for the modulation of FGF-1 and FGF-2.
    Pye DA; Vivès RR; Hyde P; Gallagher JT
    Glycobiology; 2000 Nov; 10(11):1183-92. PubMed ID: 11087710
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Participation of syndecan 2 in the induction of stress fiber formation in cooperation with integrin alpha5beta1: structural characteristics of heparan sulfate chains with avidity to COOH-terminal heparin-binding domain of fibronectin.
    Kusano Y; Oguri K; Nagayasu Y; Munesue S; Ishihara M; Saiki I; Yonekura H; Yamamoto H; Okayama M
    Exp Cell Res; 2000 May; 256(2):434-44. PubMed ID: 10772816
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular modeling studies on binding of bFGF to heparin and its receptor FGFR1.
    Lam K; Rao VS; Qasba PK
    J Biomol Struct Dyn; 1998 Jun; 15(6):1009-27. PubMed ID: 9669548
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Noncompetitive, chemokine-mediated inhibition of basic fibroblast growth factor-induced endothelial cell proliferation.
    Presta M; Belleri M; Vecchi A; Hesselgesser J; Mantovani A; Horuk R
    J Biol Chem; 1998 Apr; 273(14):7911-9. PubMed ID: 9525887
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transforming growth factor-beta 1 increases internalization of basic fibroblast growth factor by smooth muscle cells: implication of cell-surface heparan sulphate proteoglycan endocytosis.
    Berrou E; Quarck R; Fontenay-Roupie M; Lévy-Toledano S; Tobelem G; Bryckaert M
    Biochem J; 1995 Oct; 311 ( Pt 2)(Pt 2):393-9. PubMed ID: 7487873
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Heparin-dependent fibroblast growth factor activities: effects of defined heparin oligosaccharides.
    Zhou FY; Kan M; Owens RT; McKeehan WL; Thompson JA; Linhardt RJ; Höök M
    Eur J Cell Biol; 1997 May; 73(1):71-80. PubMed ID: 9174673
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Platelet factor 4 modulates the mitogenic activity of basic fibroblast growth factor.
    Watson JB; Getzler SB; Mosher DF
    J Clin Invest; 1994 Jul; 94(1):261-8. PubMed ID: 8040268
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structural specificity in a FGF7-affinity purified heparin octasaccharide required for formation of a complex with FGF7 and FGFR2IIIb.
    Luo Y; Ye S; Kan M; McKeehan WL
    J Cell Biochem; 2006 Apr; 97(6):1241-58. PubMed ID: 16315317
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor.
    Maccarana M; Casu B; Lindahl U
    J Biol Chem; 1994 Feb; 269(5):3903. PubMed ID: 8106436
    [No Abstract]   [Full Text] [Related]  

  • 51. Oligosaccharides corresponding to the regular sequence of heparin: chemical synthesis and interaction with FGF-2.
    Tabeur C; Mallet JM; Bono F; Herbert JM; Petitou M; Sinaÿ P
    Bioorg Med Chem; 1999 Sep; 7(9):2003-12. PubMed ID: 10530949
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interaction of basic fibroblast growth factor with bovine growth plate chondrocytes.
    Trippel SB; Whelan MC; Klagsbrun M; Doctrow SR
    J Orthop Res; 1992 Sep; 10(5):638-46. PubMed ID: 1323648
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting.
    Naggi A; Casu B; Perez M; Torri G; Cassinelli G; Penco S; Pisano C; Giannini G; Ishai-Michaeli R; Vlodavsky I
    J Biol Chem; 2005 Apr; 280(13):12103-13. PubMed ID: 15647251
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Heparan sulfate primed on beta-D-xylosides restores binding of basic fibroblast growth factor.
    Miao HQ; Fritz TA; Esko JD; Zimmermann J; Yayon A; Vlodavsky I
    J Cell Biochem; 1995 Feb; 57(2):173-84. PubMed ID: 7759555
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fibroblast growth factor-2 binds to small heparin-derived oligosaccharides and stimulates a sustained phosphorylation of p42/44 mitogen-activated protein kinase and proliferation of rat mammary fibroblasts.
    Delehedde M; Lyon M; Gallagher JT; Rudland PS; Fernig DG
    Biochem J; 2002 Aug; 366(Pt 1):235-44. PubMed ID: 12000311
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structural studies on the tri- and tetrasaccharides isolated from porcine intestinal heparin and characterization of heparinase/heparitinases using them as substrates.
    Yamada S; Sakamoto K; Tsuda H; Yoshida K; Sugahara K; Khoo KH; Morris HR; Dell A
    Glycobiology; 1994 Feb; 4(1):69-78. PubMed ID: 8186552
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Proliferation of endothelial cells on surface-immobilized albumin-heparin conjugate loaded with basic fibroblast growth factor.
    Bos GW; Scharenborg NM; Poot AA; Engbers GH; Beugeling T; van Aken WG; Feijen J
    J Biomed Mater Res; 1999 Mar; 44(3):330-40. PubMed ID: 10397936
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Discrete binding patterns of two heparin-reactive proteins, basic fibroblast growth factor and peptide p5R, in amyloid-laden and healthy mice.
    Martin EB; Donnell R; Richey T; Stuckey A; Kennel SJ; Wall JS
    Biochem Biophys Res Commun; 2021 May; 552():136-141. PubMed ID: 33744761
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neutralizing antibodies inhibit the binding of basic fibroblast growth factor to its receptor but not to heparin.
    Kurokawa M; Doctrow SR; Klagsbrun M
    J Biol Chem; 1989 May; 264(13):7686-91. PubMed ID: 2540201
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Endothelial proteoglycans inhibit bFGF binding and mitogenesis.
    Forsten KE; Courant NA; Nugent MA
    J Cell Physiol; 1997 Aug; 172(2):209-20. PubMed ID: 9258342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.